HSI (OTC Pink: VRTY) is Leading the Paradigm Shift of Testing Patients With Opioid Alternatives for Pain Management
NEW YORK, NY / ACCESSWIRE / December 10, 2019 / Healthcare Solutions Holdings Inc. (OTC Pink:VRTY), a medical service and...
Day: December 10, 2019
Hepion Pharmaceuticals Successfully Advances to Next Dosing Level in Ongoing Multiple Ascending Dose Clinical Study of CRV431
EDISON, NJ / ACCESSWIRE / December 10, 2019 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development of therapeutic...
CUSMA Agreement on IP Protection Puts Canadian Innovation at Risk
OTTAWA, ON / ACCESSWIRE / December 10, 2019 / "The revised Intellectual Property Provisions negotiated as part of the Canada US...
NanoVibronix, Inc. to Present at the Investor Summit on December 17th in Philadelphia
PHILADELPHIA, PA / ACCESSWIRE / December 10, 2019 / NanoVibronix, Inc. (NASDAQ:NAOV), will be presenting at this year's Investor Summit...
Akers Biosciences to Present at the Investor Summit on December 17th in Philadelphia
THOROFARE, NJ / ACCESSWIRE / December 10, 2019 / Akers Biosciences, Inc. (NASDAQ:AKER), will be presenting at this year's Investor...
Wyckoff Heights Medical Center goes live with Sunrise EHR
Sunrise™ Acute Care, Sunrise™ Revenue Cycle, Sunrise™ Radiology, Sunrise™ HIM Sunrise™ Pharmacy now deployed, as well Allscripts patient engagement platform,...
Imperative Care Announces $85 Million Series C Financing for Innovative Stroke Treatments
Funds to Fuel Commercialization of Breakthrough Technologies in Stroke Care to Enable Improved Patient Outcomes CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc....
Cyclo Therapeutics’ Chief Scientific Officer Appointed to President’s Council of Advisors on Science and Technology
ORLANDO, Fla / ACCESSWIRE / December 10, 2019 / Sharon H. Hrynkow, Ph.D., Chief Scientific Officer of Cyclo Therapeutics (OTCQB:...
Streamline Health(R) To Delay Third Quarter 2019 Earnings Announcement to Resolve Amortization Expenses From Certain Software Projects
Company Anticipates No Impact on FY 2019 Revenue, Adjusted EBITDA or Cash Flow Third Quarter 2019 Earnings to Be Announced...